Essex Woodlands Health Ventures, Inc. built an about 27.04% stake in Corium International, Inc. (CORI)

Corium International, Inc. (NASDAQ:CORI) is now up 285.59% compared to a 12-month low of $2.67. We have seen the price to move -3.74% lower and get settled at $10.3 on Oct. 10, 2017. At recent session, it appeared stuck in a range of $10.02 to $10.69. This company shares are 22.33% off its target price of $12.6 and the current market capitalization stands at $370.08M. The recent change has given its price a 12.75% lead over SMA 50 and -9.41% deficit over its 52-week high. The stock witnessed 7.18% gains, 12.32% gains and 119.15% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found CORI’s volatility during a week at 3.4% and during a month it has been found around 4.95%.

Corium International, Inc. (CORI) Top Holders

Institutional investors currently hold around $347 million or 91% in CORI stock. Look at its top three institutional owners. Essex Woodlands Health Ventures, Inc. owns $100.08 million in Corium International, Inc., which represents roughly 27.04% of the company’s market cap and approximately 28.84% of the institutional ownership. Similar statistics are true for the second largest owner, Perceptive Advisors Llc, which owns 5,847,133 shares of the stock are valued at $62.56 million. The third largest holder is Broadfin Capital, Llc, which currently holds $47.47 million worth of this stock and that ownership represents nearly 12.83% of its market capitalization.

Corium International, Inc. 13F Filings

At the end of June reporting period, 43 institutional holders increased their position in Corium International, Inc. (NASDAQ:CORI) by some 8,807,426 shares, 10 decreased positions by 1,179,017 and 2 held positions by 22,440,050. That puts total institutional holdings at 32,426,493 shares, according to SEC filings. The stock grabbed 28 new institutional investments totaling 1,572,917 shares while 2 institutional investors sold out their entire positions totaling 14,562 shares.

Corium International, Inc. (NASDAQ:CORI) Insider Trades

Multiple company employees have indulged in significant insider trading. Corium International, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that 10% Owner Broadfin Healthcare Master Fun has sold 218,100 shares of Corium International, Inc. (CORI) in trading session dated Oct. 04, 2017. These shares are worth $2,401,281 and were traded at $11.01 each. The SEC filing shows that Singh Parminder performed a sale of 30,415 shares. The CTO & Vice President, R&D disposed these shares by way of transaction on Aug. 22, 2017. The company’s shares were given away at $7.59 per share worth to an income of some $230,850 on account of Singh Parminder.

CTO & Vice President, R&D, Singh Parminder, sold 32,000 common shares of Corium International, Inc. (CORI) in the open market. In a transaction dated Aug. 17, 2017, the shares were put up for sale at an average price of $7.61, raking in a sum of $243,520. After this sale, 38,355 common shares of CORI are directly owned by the insider, with total stake valued at $395,057.

In the transaction dated Aug. 17, 2017, the great number of shares disposed came courtesy the Chief Accounting Officer; Sweemer Timothy D disposed a total of 27,500 shares at an average price of $7.73, amounting to approximately $212,575. The insider now directly owns 32,355 shares worth $333,257.

Corium International, Inc. (CORI) Analyst Guide

Several analysts have released their opinion on Corium International, Inc. (NASDAQ:CORI), with 3 analysts believing it is a strong buy. Whereas 0 of them predict the stock is a hold. Also, there are 1 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1.25 average brokerage recommendation.

SHARE
Previous articleAcadian Asset Management Llc Now Holds $2.87 million Worth Of Applied Genetic Technologies Corporation (AGTC)
Next articleHighlander Capital Management, Llc is the second biggest holder of Rosetta Genomics Ltd. (ROSG)